Business
Starpharma (ASX:SPL) share price dips on quarterly update // The Motley Fool Australia
The Starpharma Holdings Limited (ASX: SPL) share price has dipped slightly today after the company released its quarterly cashflow and activities report for the quarter ended 31 December 2020.
Starpharma is a global biopharmaceutical company that develops pharmaceutical and medical products based on proprietary polymers called dendrimers. Dendrimers are man-made nanoscale compounds that can be used both to enhance existing health products and as entirely new products.
The company is presently developing Viraleze, an antiviral nasal spray for COVID-19 that is complementary to vaccines and other preventative measures.
Here are some highlights from the company’s quarterly update.
Starpharma developments during the December…
-
Business24 hours agoThe ultimate Australian stocks to buy and hold for 10+ years
-
Noosa News19 hours agoLNP Premier David Crisafulli announces ‘Queensland’s royal commission’ into CFMEU
-
Noosa News19 hours agoMan stabbed in physical altercation on the Sunshine Coast
-
General15 hours agoAlgal bloom ‘disaster’ prompts royal commission call as impact spreads to mussel farms